ASU Biodesign Institute | |
---|---|
![]() | |
![]() | |
General information | |
Type | Research Institute |
Location | Arizona State University: Tempe Campus |
Address | 727 E. Tyler St. Tempe, Arizona 85287 |
Coordinates | 33°25′10″N 111°55′41″W / 33.41944°N 111.92806°W |
Construction started | Building A – February 2003 Building B – March 2004 Building C – October 2016 Building D – TBD |
Completed | Building A – January 2005 Building B – January 2006 Building C – September 2018 Building D – TBD |
Cost | Building A – $72.8 million Building B – $78.5 million Building C – $120 million Building D – TBD |
Owner | Arizona State University |
Technical details | |
Structural system | Brick and glass curtain wall system, steel frame, concrete flooring |
Floor count | 6 |
Floor area | Building A – 177,661 s.f. Building B – 174,583 s.f Building C – 189,000 s.f. Building D – TBD |
Design and construction | |
Architecture firm | Buildings A & B – Gould Evans / Lord Aeck & Sargent Building C – ZGF Architects / BWS Architects Building D – TBD |
Main contractor | Buildings A & B – DPR Construction / Sundt Corp. Building C – McCarthy Construction Building D – TBD |
Awards and prizes | Building A – Gold-level LEED certified Building B – Platinum-level LEED certified Building C – TBD |
Website | |
biodesign.asu.edu |
The Biodesign Institute is a major research center known for nature-inspired solutions to global health, sustainability, and security challenges located on the Tempe campus of Arizona State University. The institute is organized into a growing number of collaborative research centers and laboratories staffed by scientists in diverse disciplines. It is currently led by Executive Director Dr. Joshua LaBaer, a personalized diagnostics researcher.[1]
Overview
[edit]The Biodesign Institute performs biomedical and health research and develops solutions for environmental sustainability. The institute has more than 1300 faculty, staff and students, which include one Nobel Prize winner and National Academy member.[2] The institute has attracted more than $760 million in extramural funding from competitive grant awards, filed 860 invention disclosures, nearly 200 patents, and 35 spinouts.[3]
The Biodesign Institute is located on the Tempe campus of Arizona State University, a comprehensive multi-campus metropolitan university that is the largest in the U.S. by enrollment. The labs are housed in multiple buildings covering nearly 540,000 sqft.[4]
COVID-19 response
[edit]During the COVID-19 pandemic, the institute took a lead role and established a clinical testing laboratory, and processed nearly 500,000 tests.[5] The institute has developed a saliva based testing and got emergency approval from FDA.[6][7] The institute was named one of the Governor's Celebration of Innovation's Innovators of the Year for their work on saliva-based COVID-19 tests.[8] The institute received a $6M state contract to develop a rapid 20-minute saliva testing.[9]
Centers within the institute
[edit]- ASU-Banner Neurodegenerative Disease Research Center
- Biodesign Center for Applied Structural Discovery
- Biodesign Center for Biocomputing, Security and Society
- Biodesign Center for Bioelectronics and Biosensors
- Biodesign Center for Bioenergetics
- Biodesign Swette Center for Environmental Biotechnology
- Biodesign Center for Environmental Health Engineering
- Biodesign Center for Fundamental and Applied Microbiomics
- Biodesign Center for Health Through Microbiomes
- Biodesign Center for Immunotherapy, Vaccines and Virotherapy
- Biodesign Center for Innovations in Medicine
- Biodesign Center for Mechanisms of Evolution
- Biodesign Center for Molecular Design and Biomimetics
- Pathfinder Center
- Biodesign Center for Single Molecule Biophysics
- Biodesign Center for Sustainable Macromolecular Materials and Manufacturing
- Virginia G. Piper Center for Personalized Diagnostics
Leadership
[edit]- Joshua LaBaer, a physician-scientist specializing in personalized diagnostics, was appointed interim executive director of the Biodesign Institute in January 2016.[10] He became permanent executive director in March 2017.[11]
- Raymond DuBois, a physician-scientist with expertise in translational cancer research, was appointed executive director of the Biodesign Institute on December 1, 2012.
- Alan Nelson, an entrepreneur and a developer of a number of medical devices, was the executive director of the Biodesign Institute from March 2009 to July 2011.
- The institute was formerly led by George Poste, a scientist and policy maker with four decades of experience spanning academia, industry and government. Dr. Poste's experience in fostering scientific collaboration has shaped the institute's organization and has facilitated recruitment of international-caliber scientists to the institute.
- Charles Arntzen served as the founding director of the Biodesign Institute until May 2003, and as co-director of the Center for Infectious Diseases and Vaccinology of that Institute until 2007.
Landscape
[edit]Designed by Ten Eyck Landscape Architects as a "green gateway" to the research facility set within the desert the landscape of the Biodesign Institute uses harvested stormwater and condensate to function as a riparian area. The 4-acre site aims "to create an environment that is about healing and sustaining life". TELA achieved this by replacing the prevalent asphalt with "permeable, vibrant, shade-giving regional gardens with plants used for healing purposes", using recycled water to feed these gardens, and most importantly "connecting people in an urban setting...with the natural beauty of our long ago altered Sonoran Desert". Beyond the gardens, the site features bike lanes, pedestrian malls, seatwalls, and bioswales that all function to bring people into contact with each other and nature. Upon completion, the project won an ASLA Honor Award in the General Design Category in 2009.[12]
Gallery
[edit]-
The east side of the Biodesign Institute building
-
The main entrance to the Biodesign Institute building
-
Biodesign Institute Buildings A & B
References
[edit]- ^ "ASU names LaBaer interim executive director of the Biodesign Institute | The Biodesign Institute | ASU". biodesign.asu.edu. Retrieved 2017-10-25.
- ^ "The Institute". Biodesign Institute | ASU. Retrieved 2021-04-07.
- ^ "Impact". Biodesign Institute | ASU. Retrieved 2021-04-07.
- ^ "The Institute". Biodesign Institute | ASU. Retrieved 2021-04-07.
- ^ "Issuu reader embeds". e.issuu.com. Retrieved 2021-04-07.
- ^ "ASU Biodesign Institute Develops New COVID-19 Test Using Saliva". KJZZ. 2020-07-13. Retrieved 2021-04-07.
- ^ Steinbach, Alison. "ASU develops new saliva-based COVID-19 test as alternative to nasal swabs". The Arizona Republic. Retrieved 2021-04-07.
- ^ "Biodesign Institute wins statewide innovation award for COVID-19 tests". The Arizona State Press. Retrieved 2021-04-07.
- ^ "ASU researchers receive $6M state contract to develop rapid, 20-minute COVID-19 saliva test | Media Relations and Strategic Communications". newsroom.asu.edu. Retrieved 2021-04-07.
- ^ "ASU names LaBaer interim executive director of Biodesign Institute". ASU Now: Access, Excellence, Impact. 2016-01-13. Retrieved 2017-10-25.
- ^ "ASU appoints Josh LaBaer, M.D., Ph.D., as new executive director | The Biodesign Institute | ASU". biodesign.asu.edu. Retrieved 2017-10-25.
- ^ "2009 Professional Awards". www.asla.org. Retrieved 2018-12-04.